These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 10581055)

  • 1. Ethicists bemoan shortened clinical trial approval time.
    Dove A
    Nat Med; 1999 Dec; 5(12):1336. PubMed ID: 10581055
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical trials committees: how long is the protocol review and approval process in Spain? A prospective study.
    Ortega R; Dal-Ré R
    IRB; 1995; 17(4):6-9. PubMed ID: 11654218
    [No Abstract]   [Full Text] [Related]  

  • 3. New European clinical trial regulations are "unacceptable" to industry.
    Davidson S
    Nat Biotechnol; 1998 Feb; 16(2):127. PubMed ID: 9487504
    [No Abstract]   [Full Text] [Related]  

  • 4. Federal regulation of REB review of clinical trials: a modest but easy step towards an accountable REB review structure in Canada.
    Lemmens T
    Health Law Rev; 2005; 13(2-3):39-50. PubMed ID: 16459413
    [No Abstract]   [Full Text] [Related]  

  • 5. Informed consent and approval by institutional review boards in published reports on clinical trials.
    Ruiz-Canela M; Martínez-González MA; Gómez-Gracia E; Fernández-Crehuet J
    N Engl J Med; 1999 Apr; 340(14):1114-5. PubMed ID: 10206829
    [No Abstract]   [Full Text] [Related]  

  • 6. The roles and functions of hospital-based ethics committees.
    Kluge EH
    CMAJ; 1996 Apr; 154(7):1094-5. PubMed ID: 8625033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethics in clinical research: searching for absolutes.
    Joseph KS
    CMAJ; 1998 May; 158(10):1303-5. PubMed ID: 9614823
    [No Abstract]   [Full Text] [Related]  

  • 8. Ethical oversight of research in developing countries.
    Kass N; Dawson L; Loyo-Berrios NI
    IRB; 2003; 25(2):1-10. PubMed ID: 12833901
    [No Abstract]   [Full Text] [Related]  

  • 9. Multicenter trials and subject eligibility: should local IRBs play a role?
    Freedman B
    IRB; 1994; 16(1-2):1-6. PubMed ID: 11652320
    [No Abstract]   [Full Text] [Related]  

  • 10. Report says institutional review boards are conducting inadequate reviews.
    Maloney DM
    Hum Res Rep; 1998 Sep; 13(9):1-2. PubMed ID: 11660603
    [No Abstract]   [Full Text] [Related]  

  • 11. Institutional review boards and medical devices.
    Less JR; Alpert S; Nightingale SL
    JAMA; 1994 Sep; 272(12):968-9. PubMed ID: 8084066
    [No Abstract]   [Full Text] [Related]  

  • 12. Continued concern: human subject protection, the institutional review board, and continuing review.
    Hoffman S
    Tenn Law Rev; 2001; 68(4):725-70. PubMed ID: 16189912
    [No Abstract]   [Full Text] [Related]  

  • 13. Proposal for a good clinical practice directive.
    European Commission
    Bull Med Ethics; 1998 Feb; No. 135():6-11. PubMed ID: 11657249
    [No Abstract]   [Full Text] [Related]  

  • 14. The difficulties and costs of ethical assessment of a national research project.
    Dockerty JD; Elwood M
    N Z Med J; 1992 Aug; 105(939):311-3. PubMed ID: 1501815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethics of clinical trials for research ethics boards: proceedings of a national workshop.
    National Council on Bioethics in Human Research (Canada)
    NCBHR Commun; 1991; 2(2):4-23. PubMed ID: 11659919
    [No Abstract]   [Full Text] [Related]  

  • 16. Increased review responsibilities for Australian institutional ethics committees.
    Darvall L
    IRB; 1995; 17(1):9. PubMed ID: 11653062
    [No Abstract]   [Full Text] [Related]  

  • 17. Protecting and promoting the human research subject: a review of the function of research ethics boards in Canadian faculties of medicine.
    National Council on Bioethics in Human Research (Canada). Working Group on Evaluation
    NCBHR Commun; 1995; 6(1):3-32. PubMed ID: 11654937
    [No Abstract]   [Full Text] [Related]  

  • 18. New federal guidance adds duties for institutional review boards (IRBs).
    Maloney DM
    Hum Res Rep; 2005 Nov; 20(11):1-2. PubMed ID: 16358479
    [No Abstract]   [Full Text] [Related]  

  • 19. Continuing IRB review when research activity is limited to routine follow-up evaluations.
    Amdur RJ; Bankert E
    IRB; 1997; 19(1):7-10. PubMed ID: 11654739
    [No Abstract]   [Full Text] [Related]  

  • 20. IRBs and randomized clinical trials.
    Meinert CL
    IRB; 1998; 20(2-3):9-12. PubMed ID: 11656915
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.